MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation-Reference-Cited by-同舟云学术

MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation

Published:2014-05 Issue:5 Volume:1843 Page:955-964
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Gemelli Claudia,Zanocco Marani Tommaso,Bicciato Silvio,Mazza Emilia M.C.,Boraschi Diana,Salsi Valentina,Zappavigna Vincenzo,Parenti Sandra,Selmi Tommaso,Tagliafico Enrico,Ferrari Sergio,Grande Alexis

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference49 articles.

1. Integrin signals, transcription factors, and monocyte differentiation;Shi;Trends Cardiovasc. Med.,2006

2. Transcription factors in myeloid development: balancing differentiation with transformation;Rosenbauer;Nat. Rev. Immunol.,2007

3. Determinants of lymphoid–myeloid lineage diversification;Laiosa;Annu. Rev. Immunol.,2006

4. Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells;Gemelli;Cell Death Differ.,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of a young child with multicentric carpotarsal osteolysis exhibiting joint inflammation and dysfunctional bone formation;Bone Reports;2023-12

2. Tumor−associated macrophage polarization in the inflammatory tumor microenvironment;Frontiers in Oncology;2023-02-02

3. De-novoreconstruction and identification of transcriptional gene regulatory network modules differentiating single-cell clusters;NAR Genomics and Bioinformatics;2023-01-10

4. First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis;Therapeutic Advances in Neurological Disorders;2023-01

5. IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4;Investigational New Drugs;2022-02-28